The Role of Galectin-3 as a Marker of Cancer and Inflammation in a Stage IV Ovarian Cancer Patient with Underlying Pro-Inflammatory Comorbidities.

Case Rep Oncol · 2013 · PMC3724131 · PMID 23898279

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Clinical and preclinical studies have shown that blocking galectin-3 could have a highly significant impact on inflammation reduction, fibrotic change, tumor progression, and metastatic spread.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.